Methyl substitution on the piperidine ring of N-[omega-(6-methoxynaphthalen-1-yl)alkyl] derivatives as a probe for selective binding and activity at the sigma(1) receptor.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2005-12-29

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM050654OPMID 16366605
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and in vivo evaluation of a new PET radioligand for studying sigma-2 receptors.

  2005cited by this paper
• Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders.

  2004cited by this paper
• Antiproliferative and cytotoxic effects of some sigma2 agonists and sigma1 antagonists in tumour cell lines.

  2004cited by this paper
• Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo.

  2004cited by this paper
• Sigma receptors: biology and therapeutic potential

  2004cited by this paper
• 4-(tetralin-1-yl)- and 4-(naphthalen-1-yl)alkyl derivatives of 1-cyclohexylpiperazine as sigma receptor ligands with agonist sigma2 activity.

  2004cited by this paper
• Molecular modeling of sigma 1 receptor ligands: a model of binding conformational and electrostatic considerations.

  2004cited by this paper
• Synthesis of chiral 1-[omega-(4-chlorophenoxy)alkyl]-4-methylpiperidines and their biological evaluation at sigma1, sigma2, and sterol delta8-delta7 isomerase sites.

  2003cited by this paper
• Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction.

  2003cited by this paper
• sigma(2) Receptors regulate changes in sphingolipid levels in breast tumor cells.

  2002cited by this paper
• Improving Alzheimer's Disease-Related Cognitive Deficits with sigma1 Receptor Agonists.

  2002cited by this paper
• Synthesis and evaluation of [18F]fluoroethyl SA4503 as a PET ligand for the sigma receptor

  2002cited by this paper
• N-arylalkylpiperidines as high-affinity sigma-1 and sigma-2 receptor ligands: phenylpropylamines as potential leads for selective sigma-2 agents.

  2002cited by this paper
• Probing the proposed phenyl-A region of the sigma-1 receptor.

  2002cited by this paper
• Effect of the novel sigma1 receptor ligand and putative atypical antipsychotic E-5842 on BDNF mRNA expression in the rat brain

  2002cited by this paper
• Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines.

  2002cited by this paper
• Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1.

  2002cited by this paper
• A multireceptorial binding reinvestigation on an extended class of sigma ligands: N-[omega-(indan-1-yl and tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine reveal high affinities towards sigma1 and EBP sites.

  2001cited by this paper
• Regulating ankyrin dynamics: Roles of sigma-1 receptors.

  2001cited by this paper
• Labelled sigma receptor ligands: can their role in neurology and oncology be extended?

  2001cited by this paper
• [99mTc]oxotechnetium(V) complexes amine-amide-dithiol chelates with dialkylaminoalkyl substituents as potential diagnostic probes for malignant melanoma.

  2001cited by this paper
• Beneficial effect of the sigma(1) receptor agonist PRE-084 against the spatial learning deficits in aged rats.

  2001cited by this paper
• Simultaneous evaluation of dual gene transfer to adherent cells by gamma-ray imaging.

  2001cited by this paper
• In vivo evaluation of [(11)C]SA4503 as a PET ligand for mapping CNS sigma(1) receptors.

  2000cited by this paper
• Sigma receptors: recent advances and new clinical potentials.

  2000cited by this paper
• Is a nitrogen atom an important pharmacophoric element in sigma ligand binding?

  2000cited by this paper
• A sigma-1 receptor selective analogue of BD1008. A potential substitute for (+)-opioids in sigma receptor binding assays.

  2000cited by this paper
• Design, synthesis, structure-activity relationships, and biological characterization of novel arylalkoxyphenylalkylamine sigma ligands as potential antipsychotic drugs.

  1999cited by this paper
• Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding

  1999cited by this paper
• N-[omega-(Tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine are highly potent and selective sigma1 or sigma2 ligands.

  1998cited by this paper
• The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis.

  1997cited by this paper
• Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1).

  1996cited by this paper
• Structure-activity relationship studies on the 5-HT(1A) receptor affinity of 1-phenyl-4-[omega-(alpha- or beta-tetralinyl)alkyl]piperazines. 4.

  1996cited by this paper
• Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism.

  1995cited by this paper
• Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.

  1995cited by this paper
• Structural features important for sigma 1 receptor binding.

  1994cited by this paper
• Purification and amino-terminal sequencing of the high affinity phenylalkylamine Ca2+ antagonist binding protein from guinea pig liver endoplasmic reticulum.

  1994cited by this paper
• A proposal for the classification of sigma binding sites.

  1992cited by this paper

• A conformational rearrangement of the SARS-CoV-2 host protein sigma-1 is required for antiviral activity: insights from a combined in-silico/in-vitro approach

  2023cites this paper
• Terminal Phenoxy Group as a Privileged Moiety of the Drug Scaffold—A Short Review of Most Recent Studies 2013–2022

  2022cites this paper
• Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σ1) receptor ligands with potent anti-amnesic effect.

  2021cites this paper
• QSAR-Based Computational Approaches to Accelerate the Discovery of Sigma-2 Receptor (S2R) Ligands as Therapeutic Drugs

  2021cites this paper
• Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders

  2021cites this paper
• Multi-Target Directed Ligands (MTDLs) Binding the σ1 Receptor as Promising Therapeutics: State of the Art and Perspectives

  2021cites this paper
• PB28, the Sigma-1 and Sigma-2 Receptors Modulator With Potent Anti–SARS-CoV-2 Activity: A Review About Its Pharmacological Properties and Structure Affinity Relationships

  2020cites this paper
• In vitro and in vivo sigma 1 receptor imaging studies in different disease states.

  2020cites this paper
• High-affinity sigma-1 (σ1) receptor ligands based on the σ1 antagonist PB212.

  2019cites this paper
• Multifunctional thiosemicarbazones and deconstructed analogues as a strategy to study the involvement of metal chelation, Sigma-2 (σ2) receptor and P-gp protein in the cytotoxic action: In vitro and in vivo activity in pancreatic tumors.

  2018cites this paper
• Novel Sigma-1 receptor antagonists: from opioids to small molecules: what is new?

  2018cites this paper
• Synthesis, radiolabelling, and evaluation of [11C]PB212 as a radioligand for imaging sigma-1 receptors using PET.

  2018cites this paper
• Development of sigma-1 (σ1) receptor fluorescent ligands as versatile tools to study σ1 receptors.

  2016influential citation
• Design, synthesis, and biological evaluation of sigma receptors (σRS) ligands as potential pharmacotherapy for cancer and drug addiction

  2015cites this paper
• Live imaging reveals a new role for the sigma-1 (σ1) receptor in allowing microglia to leave brain injuries.

  2015cites this paper
• One-pot synthesis of 3-azido- and 3-aminopiperidines by intramolecular cyclization of unsaturated amines.

  2014cites this paper
• The effects of new sigma (σ) receptor ligands, PB190 and PB212, in the models predictive of antidepressant activity

  2014cites this paper
• Investigation of σ receptors agonist/antagonist activity through N-(6-methoxytetralin-1-yl)- and N-(6-methoxynaphthalen-1-yl)alkyl derivatives of polymethylpiperidines.

  2013cites this paper
• New positron emission tomography (PET) radioligand for imaging σ-1 receptors in living subjects.

  2012cites this paper
• Effects of PB 190 and PB 212 , new receptor ligands , on glucocorticoid receptor-mediated gene transcription in LMCAT cells

  2012cites this paper
• The sigma-1 receptor antagonist PB212 reduces the Ca²⁺-release through the inositol (1, 4, 5)-trisphosphate receptor in SK-N-SH cells.

  2012cites this paper
• AsteriX: A Web Server To Automatically Extract Ligand Coordinates from Figures in PDF Articles

  2012cites this paper
• Synthesis and binding assays of novel 3,3-dimethylpiperidine derivatives with various lipophilicities as σ₁ receptor ligands.

  2011cites this paper
• Synthesis of carbon-11-labeled piperidine ring of N-[omega-(6-methoxynaphthalen-1-yl)alkyl] derivatives as new selective PET sigma1 receptor probes.

  2010cites this paper
• A structure-affinity and comparative molecular field analysis of sigma-2 (sigma2) receptor ligands.

  2009cites this paper
• Exploring the importance of piperazine N-atoms for sigma(2) receptor affinity and activity in a series of analogs of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28).

  2009cites this paper
• 1-Cyclohexylpiperazine and 3,3-Dimethylpiperidine Derivatives as Sigma-1 (σ1) and Sigma-2 (σ2) Receptor Ligands: A Review

  2009cites this paper
• Small molecule receptors as imaging targets.

  2008cites this paper
• Novel 4-(4-aryl)cyclohexyl-1-(2-pyridyl)piperazines as Delta(8)-Delta(7) sterol isomerase (emopamil binding protein) selective ligands with antiproliferative activity.

  2008cites this paper
• An update on the development of drugs for neuropsychiatric disorders: focusing on the σ1 receptor ligand

  2008cites this paper
• Novel 4-( 4-Aryl ) cyclohexyl-1-( 2-pyridyl ) piperazines as ∆ 8-∆ 7 Sterol Isomerase ( Emopamil Binding Protein ) Selective Ligands with Antiproliferative Activity

  2008cites this paper
• Design and evaluation of naphthol- and carbazole-containing fluorescent sigma ligands as potential probes for receptor binding studies.

  2007cites this paper